KRAS and colorectal carcinoma: Some recent studies have shown, for example, that patients with CRC microsatellite stable (MSS) disease do not respond effectively to PD-1 Immune Checkpoint Blockage (ICB), and this is caused by mutations on the oncogene KRAS, which induces the recruitment of MDSC and Treg cells [125].